immunobiotec.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# # robots.txt # # This file is to prevent the crawling and indexing of certain parts # of your site by web crawlers and spiders run by sites like Yahoo! # and Google. By telling these "robots" where not to go on your site, # you save bandwidth and server resources. # # This file will be ignored unless it is at the root of your host: # Used: http://example.com/robots.txt # Ignored: http://example.com/site/robots.txt # # For more information about the robots.txt standard, see: # http://www.robotstxt.org/robotstxt.html User-agent: * Crawl-delay: 10 # CSS, JS, Images Allow: /misc/*.css$ Allow: /misc/*.css? Allow: /misc/*.js$ Allow: /misc/*.js? Allow: /misc/*.gif Allow: /misc/*.jpg Allow: /misc/*.jpeg Allow: /misc/*.png Allow: /modules/*.css$ Allow: /modules/*.css? Allow: /modules/*.js$ Allow: /modules/*.js? Allow: /modules/*.gif Allow: /modules/*.jpg Allow: /modules/*.jpeg Allow: /modules/*.png Allow: /profiles/*.css$ Allow: /profiles/*.css? Allow: /profiles/*.js$ Allow: /profiles/*.js? | ||
Meta Tags
| Title | ImmunoBiochem |
| Description | Home About Technology Pipeline News Contact Technology ImmunoBiochem is developing potentiated biologics targeted at novel tumor antigens that are augment |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 74.208.236.104 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
immunobiotec.com Valuation
|
US$1,194
Last updated: 2023-05-02 18:41:27
immunobiotec.com has Semrush global rank of 0. immunobiotec.com has an estimated worth of US$ 1,194, based on its estimated Ads revenue. immunobiotec.com receives approximately 137 unique visitors each day. Its web server is located in United States, with IP address 74.208.236.104. According to SiteAdvisor, immunobiotec.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,194 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$33 |
| Yearly Ads Revenue | US$396 |
| Daily Unique Visitors | 9 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| immunobiotec.com. | A | 3600 | IP: 74.208.236.104 |
| immunobiotec.com. | AAAA | 86400 | IPV6: 2607:f1c0:100f:f000::2bd |
| immunobiotec.com. | NS | 86400 | NS Record: ns1102.ui-dns.biz. |
| immunobiotec.com. | NS | 86400 | NS Record: ns1102.ui-dns.org. |
| immunobiotec.com. | NS | 86400 | NS Record: ns1102.ui-dns.com. |
| immunobiotec.com. | NS | 86400 | NS Record: ns1102.ui-dns.de. |
| immunobiotec.com. | MX | 3600 | MX Record: 10 mx00.1and1.com. |
| immunobiotec.com. | MX | 3600 | MX Record: 10 mx01.1and1.com. |
HtmlToTextCheckTime:2023-05-02 18:41:27
| Home About Technology Pipeline News Contact Technology ImmunoBiochem is developing potentiated biologics targeted at novel tumor antigens that are augmented in cancer cell secretomes and accumulate in the tumor microenvironment. This targeting approach overcomes the challenges of solid tumor heterogeneity and tumor penetration by antibodies. ImmunoBiochem is able to deliver novel immunomodulatory payloads to a variety of cell types within the tumor in a highly selective fashion, pioneering a next-generation strategy for the delivery of innate immune system modulators. READ MORE Pipeline ImmunoBiochem pipeline consists of several biologics for oncology aiming to solve the problem of tumor heterogeneity. The lead candidates, IMB-212, IMB-213I and IMB-214R, are in development for a number of difficult-to-treat solid malignancies, including rare, orphan disease. READ MORE About ImmunoBiochem Corporation is committed to developing novel, targeted biological therapeutics for oncology. READ |
HTTP Headers
HTTP/1.1 200 OK Content-Type: text/html; charset=utf-8 Connection: keep-alive Keep-Alive: timeout=15 Date: Mon, 25 Oct 2021 03:41:12 GMT Server: Apache Expires: Sun, 19 Nov 1978 05:00:00 GMT Cache-Control: no-cache, must-revalidate X-Content-Type-Options: nosniff Content-Language: en X-Frame-Options: SAMEORIGIN X-Generator: Drupal 7 (http://drupal.org) |
immunobiotec.com Whois Information
Domain Name: IMMUNOBIOTEC.COM Registry Domain ID: 1203468265_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.ionos.com Registrar URL: http://www.ionos.com Updated Date: 2021-09-08T07:23:01Z Creation Date: 2007-09-07T18:00:59Z Registry Expiry Date: 2022-09-07T18:00:59Z Registrar: 1&1 IONOS SE Registrar IANA ID: 83 Registrar Abuse Contact Email: abuse@ionos.com Registrar Abuse Contact Phone: +1.6105601459 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1102.UI-DNS.BIZ Name Server: NS1102.UI-DNS.COM Name Server: NS1102.UI-DNS.DE Name Server: NS1102.UI-DNS.ORG DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T08:34:37Z <<< |